VANGUARD GROUP INC - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 16 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$318,000
-70.7%
1,808,0980.0%0.00%
Q2 2022$1,085,000
-55.0%
1,808,098
-1.0%
0.00%
Q1 2022$2,410,000
-49.7%
1,826,131
-0.5%
0.00%
Q4 2021$4,789,000
-17.8%
1,834,903
-2.1%
0.00%
Q3 2021$5,829,000
-16.1%
1,874,573
+0.3%
0.00%
Q2 2021$6,951,000
+27.8%
1,868,664
+18.9%
0.00%
Q1 2021$5,438,000
+112.4%
1,571,586
+106.3%
0.00%
Q4 2020$2,560,000
+0.1%
761,927
+4.6%
0.00%
Q3 2020$2,557,000
-24.7%
728,678
-1.2%
0.00%
Q2 2020$3,394,000
+38.9%
737,853
-0.1%
0.00%
Q1 2020$2,444,000
-46.0%
738,678
-0.3%
0.00%
Q4 2019$4,528,000
+46.0%
741,139
-0.3%
0.00%
Q3 2019$3,101,000
-64.9%
743,633
+10.4%
0.00%
Q2 2019$8,838,000
+405.0%
673,620
+266.1%
0.00%
Q1 2019$1,750,000
+221.7%
183,994
+4.5%
0.00%
Q4 2018$544,000175,9940.00%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 1,607,044$4,194,0000.48%
NEA Management Company, LLC 6,643,704$17,340,0000.35%
Platform Technology Partners 251,723$657,0000.29%
DAFNA Capital Management LLC 378,611$988,0000.25%
Avidity Partners Management LP 4,405,000$11,497,0000.24%
Endurant Capital Management LP 360,078$940,0000.23%
Rock Springs Capital Management LP 2,581,299$6,737,0000.16%
RA Capital Management 2,850,000$7,439,0000.13%
New Legacy Group, LLC 240,575$628,0000.12%
XTX Topco Ltd 15,574$41,0000.02%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders